Trials / Completed
CompletedNCT03633240
Emergency Room Visits and Older Patients (ER2)
Emergency Room Visits and Older Patients: Assessment of Jewish General Hospital Program Screening Frail Users
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 356 (actual)
- Sponsor
- Jewish General Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- —
Summary
Today's population is living longer than prior generations. Senior patients, defined as 65 years or older, are therefore increasing in number, and representing a larger number of hospitalized patients. Thus, assessing and addressing the needs of the growing number of older ER users is essential. The overall objective of the study is to examine the feasibility and the epidemiology of two screening tools ("Programme de Recherche sur l'Intégration des Services pour le Maintien de l'Autonomie" (PRISMA-7) and Emergency Room Evaluation and recommendations (ER2)) used in the Emergency Room of Jewish General Hospital to screen older patients (i.e.; ≥65 years) at risk of adverse health events. A prospective observational cohort design will be used for the study's two phases; phase 1- assessment and phase 2- assessment as well as recommendations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ER assessment | To measure the effects of recommendations of ER2, the investigators will use ER users who will have an ER2 assessment without any recommendations as the referent group the older. This choice is possible because ER2 will be integrated into ER care in two steps: The first step will be limited to its assessment component in order to learn how to use the tool. The second step will be to follow the recommendations provided after the assessment. Participants will follow-up during their hospitalization via a review of their chart. They will be censored when they will be discharged from the JGH or when the duration of hospitalization will exceed 31 days. |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2021-09-01
- Completion
- 2024-07-01
- First posted
- 2018-08-16
- Last updated
- 2024-07-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03633240. Inclusion in this directory is not an endorsement.